Fast Market Research

"Colby Pharmaceutical Company - Product Pipeline Review - 2013" Published

Fast Market Research recommends "Colby Pharmaceutical Company - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 10/15/2013 -- Global Market Direct's pharmaceuticals report, "Colby Pharmaceutical Company - Product Pipeline Review - 2013" provides data on the Colby Pharmaceutical Company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Colby Pharmaceutical Company's corporate website, SEC filings, investor presentations and featured press releases, both from Colby Pharmaceutical Company and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- Colby Pharmaceutical Company - Brief Colby Pharmaceutical Company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Colby Pharmaceutical Company human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Colby Pharmaceutical Company with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Colby Pharmaceutical Company's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Colby Pharmaceutical Company's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Colby Pharmaceutical Company.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Colby Pharmaceutical Company - Product Pipeline Review - 2012
- Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2013
- Prostate Cancer - Pipeline Review, H2 2013
- Chugai Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013
- Lymphoma - Pipeline Review, H2 2013
- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2013
- Endometriosis - Pipeline Review, H2 2013
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013